Insider screener

Period: 12 months Role: Other officers × Minimum amount: $100K × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

14,362 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

14,362 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

14,362 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

14,362 decisions over 12 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
14,362 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
14,362 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

14,362 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
8 Jan 2026
Joseph P Lyssikatos Chief Scientific Officer · indirect
Sold on a plan 2×
$993.44K 41,302 at 24.05
4.6%
Planned (10b5-1)
8 Jan 2026
David M Carter President, DRSS Division
Sold on a plan 8×
$856.19K 8,123 at 105.40
9.0%
Planned (10b5-1)
8 Jan 2026
Martina M.D. Flammer Chief Medical Officer
Sold on a plan 2×
$854.85K 4,911 at 174.07
5.4%
Planned (10b5-1)
8 Jan 2026
Margaret Hayne Co-President & CCO · indirect
Sold on a plan 5×
$771.05K 9,333 at 82.62
0.4%
Planned (10b5-1)
8 Jan 2026
Thomas Taira President, Special Projects
Sold on a plan
$524.78K 1,174 at 447.00
1.7%
Planned (10b5-1)
8 Jan 2026
Jessica A. Garascia Senior VP, GC, CAO & Secretary
Sold at will
$455.98K 4,787 at 95.25
13.9%
Not planned
8 Jan 2026
Chad Roberts EVP, Production Solutions
Sold on a plan
$453.13K 23,428 at 19.34
12.1%
Planned (10b5-1)
8 Jan 2026
Katherine H Ramundo EVP, CLO, CCO & Secretary
Sold on a plan
$425.00K 5,000 at 85.00
4.1%
Planned (10b5-1)
8 Jan 2026
Stacey G Rock President, KTT Division
Sold on a plan 7×
$421.49K 4,000 at 105.37
8.5%
Planned (10b5-1)
8 Jan 2026
Mario Schlosser President of Technology & CTO
Sold on a plan
$406.62K 23,038 at 17.65
6.2%
Planned (10b5-1)
8 Jan 2026
John Michael Wilson Chief Quality Officer and CTO
Sold at will
$375.60K 5,000 at 75.12
7.7%
Not planned
8 Jan 2026
Roger Adsett Chief Operating Officer
Sold at will
$358.62K 2,059 at 174.17
1.9%
Not planned
8 Jan 2026
Eric Pauwels Chief Business Officer
Sold on a plan 3×
$352.06K 4,602 at 76.50
5.3%
Planned (10b5-1)
8 Jan 2026
Laura A Williams Chief Patient Officer
Sold on a plan
$348.90K 50,000 at 6.98
12.1%
Planned (10b5-1)
8 Jan 2026
Caroline Cochran Co-Founder, COO · indirect
Sold on a plan 3×
$345.54K 3,455 at 100.01
0.4%
Planned (10b5-1)
8 Jan 2026
Mark Elliott Boulding Exec. VP and CLO
Sold on a plan 3×
$308.76K 4,033 at 76.56
3.4%
Planned (10b5-1)
8 Jan 2026
Corey J Manley EVP&Chief Legal/Admin Officer
Sold on a plan
$304.69K 6,106 at 49.90
6.2%
Planned (10b5-1)
8 Jan 2026
Stuart A Tross Chief People & Workpl Officer
Sold on a plan
$297.55K 47,006 at 6.33
4.6%
Planned (10b5-1)
8 Jan 2026
Matt Mills President
Sold on a plan
$269.51K 13,771 at 19.57
0.7%
Planned (10b5-1)
8 Jan 2026
Mark S. Garfield Chief Accounting Officer
Sold on a plan
$199.71K 953 at 209.56
2.6%
Planned (10b5-1)
8 Jan 2026
Amit Dhingra Chief Enterprise Pmts Officer
Sold on a plan
$185.00K 10,000 at 18.50
6.0%
Planned (10b5-1)
8 Jan 2026
Michael Alexander Smith Chief Legal Officer
Sold at will
$183.40K 1,053 at 174.17
1.8%
Not planned
8 Jan 2026
John C Watts EVP & Chief Growth Officer
Sold on a plan
$172.80K 288 at 600.00
8.3%
Planned (10b5-1)
8 Jan 2026
Paul F. Lizzul Chief Medical Officer
Sold at will
$163.19K 3,650 at 44.71
8.0%
Not planned
8 Jan 2026
Craig C. Hopkinson EVP R&D, Chief Medical Officer
Sold on a plan
$150.01K 5,000 at 30.00
7.5%
Planned (10b5-1)
8 Jan 2026
Caroline Cochran Co-Founder, COO
Sold on a plan
$125.50K 1,255 at 100.00
0.2%
Planned (10b5-1)
8 Jan 2026
Kevin McCulloch See Remarks
Sold on a plan
$120.00K 15,000 at 8.00
0.9%
Planned (10b5-1)
8 Jan 2026
Adam B Frankel General Counsel
Sold on a plan
$119.57K 4,382 at 27.29
2.0%
Planned (10b5-1)
8 Jan 2026
Tara D Mackey Chief Legal Officer
Sold at will
$118.71K 1,000 at 118.71
3.3%
Not planned
8 Jan 2026
Timothy Price Crain II SVP and Chief Growth Officer
Sold on a plan
$113.22K 5,660 at 20.00
1.9%
Planned (10b5-1)
8 Jan 2026
Allison C Hoffman General Counsel & Secretary
Sold at will
$111.99K 6,585 at 17.01
3.6%
Not planned
8 Jan 2026
Sajal Srivastava President and CIO · indirect
Bought on a plan
$111.20K 16,833 at 6.61
0.9%
Bought on a plan
8 Jan 2026
Evan Roberts President, Provider Solutions
Sold at will
$107.43K 6,317 at 17.01
0.8%
Not planned
8 Jan 2026
David Linetsky President, Network Solutions
Sold at will
$103.85K 6,106 at 17.01
2.6%
Not planned
7 Jan 2026
Ajay K Puri EVP, Worldwide Field Ops · indirect
Sold on a plan 3×
$37.56M 200,000 at 187.82
5.0%
Planned (10b5-1)
7 Jan 2026
Caroline Cochran Co-Founder, COO · indirect
Sold on a plan 9×
$22.99M 231,658 at 99.25
21.7%
Planned (10b5-1)
7 Jan 2026
Brian M Venturo Chief Strategy Officer · indirect
Sold on a plan 4×
$12.07M 154,479 at 78.11
100%
Sold half or more
7 Jan 2026
Caroline Cochran Co-Founder, COO
Sold on a plan 7×
$9.02M 92,004 at 98.03
10.0%
Planned (10b5-1)
7 Jan 2026
Margaret A Horn Chief Operating Officer
Sold on a plan 3×
$7.54M 75,000 at 100.56
34.7%
Planned (10b5-1)
7 Jan 2026
Benjamin Seong Lee Chief Legal Officer
Sold on a plan 2×
$7.26M 27,930 at 260.08
30.8%
Planned (10b5-1)
7 Jan 2026
Suren Gupta President,Enterprise Solutions
Sold on a plan
$4.11M 19,593 at 210.00
16.3%
Planned (10b5-1)
7 Jan 2026
Shannon L. Devers EVP, Chief Human Resources Ofc
Sold on a plan 5×
$3.76M 44,199 at 85.08
71.6%
Sold half or more
7 Jan 2026
Ourania Tatsis EVP, Chief Reg. & Quality Off.
Sold on a plan
$2.14M 4,500 at 474.99
9.6%
Planned (10b5-1)
7 Jan 2026
Carl Dambkowski Chief Medical Officer
Sold on a plan 4×
$1.46M 18,700 at 77.84
8.1%
Planned (10b5-1)
7 Jan 2026
Mohamed Khairie Issa EVP, Head of US Oncology
Sold on a plan
$1.18M 10,856 at 109.07
14.1%
Planned (10b5-1)
7 Jan 2026
Terilyn J. Monroe Chief People Officer
Sold on a plan 3×
$1.12M 10,031 at 112.08
32.3%
Planned (10b5-1)
7 Jan 2026
Harold Bernstein President, R&D & CMO
Sold on a plan
$1.01M 25,156 at 40.20
100%
Sold half or more
7 Jan 2026
Lester Zitkus SVP, Land
Sold at will 3×
$881.09K 4,745 at 185.69
37.8%
Not planned
7 Jan 2026
Thomas E Mills IV President, C5ISR Division
Sold on a plan 4×
$792.45K 8,523 at 92.98
46.5%
Planned (10b5-1)
7 Jan 2026
Sold on a plan 2×
$773.87K 3,678 at 210.40
5.6%
Planned (10b5-1)
Showing 11,701–11,750 of 14,362. ← Newer Page 235 of 288 Older →